Enanta Pharmaceuticals (ENTA) Operating Income (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.32% |
| Dec 31, 2025 | 38.80% |
| Sep 30, 2025 | 2.68% |
| Jun 30, 2025 | 22.97% |
| Mar 31, 2025 | -4.18% |
| Dec 31, 2024 | 21.14% |
| Sep 30, 2024 | -23.44% |
| Jun 30, 2024 | 26.19% |
| Mar 31, 2024 | 6.08% |
| Dec 31, 2023 | -12.43% |
| Sep 30, 2023 | 15.48% |
| Jun 30, 2023 | 6.94% |
| Mar 31, 2023 | -31.45% |
| Dec 31, 2022 | -10.96% |
| Sep 30, 2022 | 16.88% |
| Jun 30, 2022 | 3.86% |
| Mar 31, 2022 | -11.31% |
| Dec 31, 2021 | 9.84% |
| Sep 30, 2021 | 0.35% |
| Jun 30, 2021 | -13.96% |
| Mar 31, 2021 | -141.48% |
| Dec 31, 2020 | 37.83% |
| Sep 30, 2020 | 13.43% |
| Jun 30, 2020 | -92.44% |
| Mar 31, 2020 | -192.26% |
| Dec 31, 2019 | 100.14% |
| Sep 30, 2019 | 71.26% |
| Jun 30, 2019 | 387.96% |
| Mar 31, 2019 | -104.68% |
| Dec 31, 2018 | -19.15% |
| Sep 30, 2018 | 52.17% |
| Jun 30, 2018 | 34.29% |
| Mar 31, 2018 | 17.26% |
| Dec 31, 2017 | -73.52% |
| Sep 30, 2017 | 513.55% |
| Jun 30, 2017 | -38.11% |
| Mar 31, 2017 | -34.91% |
| Dec 31, 2016 | -127.36% |
| Sep 30, 2016 | -184.57% |
| Jun 30, 2016 | -92.74% |
| Mar 31, 2016 | -101.59% |
| Dec 31, 2015 | 868.81% |
| Sep 30, 2015 | 115.74% |
| Jun 30, 2015 | -96.49% |
| Mar 31, 2015 | -30.83% |
| Dec 31, 2014 | 1,418.25% |
| Sep 30, 2014 | -115.26% |
| Jun 30, 2014 | 780.61% |
| Mar 31, 2014 | 6.05% |
| Dec 31, 2013 | -16.08% |
| Sep 30, 2013 | -12.52% |
| Jun 30, 2013 | -4.42% |
| Mar 31, 2013 | -118.26% |
| Dec 31, 2012 | 634.89% |
| Sep 30, 2012 | -16.10% |
| Jun 30, 2012 | -110.99% |